Navegar por autor "Pérez de Llano, Luis"

Asma corticodependiente: nuestra experiencia clínica

2015- Pallarés Sanmartín, Abel; Golpe Gómez, Rafael; Pérez de Llano, Luis; Mengual Macenlle, Noemi

Central thromboembolism as a predictor of right ventricle dysfunction in hemodynamically stable pulmonary embolism

2011- Golpe Gómez, Rafael; Pérez de Llano, Luis

Clinical differences between patients with COPD due to biomass smoke or tobacco

2014- Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Sanjuan López, María del Pilar; Cano Jiménez, Esteban Alberto [et al.]

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

2023- Hughes, R.; Rapsomaniki, E.; Bansal, A.T.; Vestbo, J.; Price, D.; [et al.]

Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

2023- Pfeffer, P.E.; Ali, N.; Murray, R.; Ulrik, C.; Tran, T.N.; [et al.]

Cost-effectiveness of asthma management in a hospital-based adult asthma clinic in Spain

2014- Pérez de Llano, Luis

Distribución de fenotipos clínicos en pacientes con enfermedad pulmonar obstructiva crónica por humo de biomasa y por tabaco

2014- Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Sanjuan López, María del Pilar; Cano Jiménez, Esteban Alberto [et al.]

Effects of omalizumab in Aspergillus-associated airway disease.

2011- Parra Arrondo, Antonio; Pérez de Llano, Luis

Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry

2013- Pérez de Llano, Luis

El óxido nítrico (NO) en el manejo del asma

2012- Pérez de Llano, Luis

Electrocardiogram score predicts severity of pulmonary embolism in hemodynamically stable patients.

2011- González Juanatey, Carlos; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Vázquez Caruncho, Manuel; [et al.]

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome

2012- Testa Fernández, Ana; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; López González, María Jesus; [et al.]

Hospital Epidemics Tracker (HEpiTracker): Description and Pilot Study of a Mobile App to Track COVID-19 in Hospital Workers

2020- Soriano, J. B.; Fernandez, E.; de Astorza, A.; Pérez de Llano, Luis; Fernández Villar, José Alberto; [et al.]

Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

2023- Chen, W.; Tran, T.N.; Sadatsafavi, M.; Murray, R.; Wong, N.C.B.; [et al.]

Long-term clinical outcome of patients with persistent right ventricle dysfunction or pulmonary hypertension after acute pulmonary embolism

2011- González Juanatey, Carlos; Testa Fernández, Ana; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; [et al.]

Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism.

2012- González Juanatey, Carlos; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Vázquez Caruncho, Manuel [et al.]

Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: A meta-analysis of 5 randomized trials in non-cancer and cancer patients.

2012- Pérez de Llano, Luis

Neumonía necrotizante por Finegoldia magna.

2011- Pérez de Llano, Luis; Pita Carretero, Julia; Sedano Gómez, Gianina Emily

Normativa sobre asma grave no controlada

2015- Pérez de Llano, Luis

Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches

2012- Pérez de Llano, Luis

O repositorio dixital RUNA

Navegar por autor "Pérez de Llano, Luis"

Asma corticodependiente: nuestra experiencia clínica ﻿

Central thromboembolism as a predictor of right ventricle dysfunction in hemodynamically stable pulmonary embolism ﻿

Clinical differences between patients with COPD due to biomass smoke or tobacco ﻿

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum ﻿

Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both ﻿

Cost-effectiveness of asthma management in a hospital-based adult asthma clinic in Spain ﻿

Distribución de fenotipos clínicos en pacientes con enfermedad pulmonar obstructiva crónica por humo de biomasa y por tabaco ﻿

Effects of omalizumab in Aspergillus-associated airway disease. ﻿

Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry ﻿

El óxido nítrico (NO) en el manejo del asma ﻿

Electrocardiogram score predicts severity of pulmonary embolism in hemodynamically stable patients. ﻿

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome ﻿

Hospital Epidemics Tracker (HEpiTracker): Description and Pilot Study of a Mobile App to Track COVID-19 in Hospital Workers ﻿

Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry ﻿

Long-term clinical outcome of patients with persistent right ventricle dysfunction or pulmonary hypertension after acute pulmonary embolism ﻿

Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism. ﻿

Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: A meta-analysis of 5 randomized trials in non-cancer and cancer patients. ﻿

Neumonía necrotizante por Finegoldia magna. ﻿

Normativa sobre asma grave no controlada ﻿

Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches ﻿

Asma corticodependiente: nuestra experiencia clínica

Central thromboembolism as a predictor of right ventricle dysfunction in hemodynamically stable pulmonary embolism

Clinical differences between patients with COPD due to biomass smoke or tobacco

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

Cost-effectiveness of asthma management in a hospital-based adult asthma clinic in Spain

Distribución de fenotipos clínicos en pacientes con enfermedad pulmonar obstructiva crónica por humo de biomasa y por tabaco

Effects of omalizumab in Aspergillus-associated airway disease.

Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry

El óxido nítrico (NO) en el manejo del asma

Electrocardiogram score predicts severity of pulmonary embolism in hemodynamically stable patients.

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome

Hospital Epidemics Tracker (HEpiTracker): Description and Pilot Study of a Mobile App to Track COVID-19 in Hospital Workers

Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

Long-term clinical outcome of patients with persistent right ventricle dysfunction or pulmonary hypertension after acute pulmonary embolism

Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism.

Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: A meta-analysis of 5 randomized trials in non-cancer and cancer patients.

Neumonía necrotizante por Finegoldia magna.

Normativa sobre asma grave no controlada

Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches